Moderna (NASDAQ:MRNA) Given New $33.00 Price Target at JPMorgan Chase & Co.
Moderna (NASDAQ:MRNA – Get Free Report) had its price objective lowered by analysts at JPMorgan Chase & Co. from $40.00 to ...
Moderna, Inc. (NASDAQ:MRNA) Given Average Recommendation of “Hold” by Analysts
Shares of Moderna, Inc. (NASDAQ:MRNA – Get Free Report) have been assigned an average rating of “Hold” from the twenty-four ...
Modern Healthcare1h
Navina lands $55M from Goldman Sachs
Navina, a clinical intelligence company, closed a $55 million Series C funding round. The round was led by a division of ...
The Daily Hodl8d
Goldman Sachs Mentions Crypto in Shareholder Letter, Says Tech Raising Competition in Banking Industry
The financial services giant Goldman Sachs is telling shareholders that its competitors are now offering crypto products and ...
Goldman Sachs names Dubner as COO global M&A-memo
Goldman Sachs named David Dubner as chief operating officer of global mergers and acquisitions, according to a memo seen by Reuters on Wednesday, beefing up leadership in one of its most important ...